Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:2292-2300, doi:10.1016/j.jacc.2007.02.050 (Published online 24 May 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.02.050v1
49/23/2292    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujimoto, K. L.
Right arrow Articles by Wagner, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, K. L.
Right arrow Articles by Wagner, W. R.
Related Collections
Right arrowRelated Article

PRECLINICAL STUDY

An Elastic, Biodegradable Cardiac Patch Induces Contractile Smooth Muscle and Improves Cardiac Remodeling and Function in Subacute Myocardial Infarction

Kazuro L. Fujimoto, MD*,{dagger}, Kimimasa Tobita, MD{dagger},{ddagger},§, W. David Merryman, PhD§, Jianjun Guan, PhD*,{dagger}, Nobuo Momoi, MD, PhD{ddagger}, Donna B. Stolz, PhD||, Michael S. Sacks, PhD{dagger},§, Bradley B. Keller, MD{dagger},{ddagger},|| and William R. Wagner, PhD*,{dagger},§,*

* Department of Surgery, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
{dagger} McGowan Institute for Regenerative Medicine, Pittsburgh, Pennsylvania
{ddagger} Department of Pediatrics, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
§ Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania
|| Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Manuscript received October 23, 2006; revised manuscript received January 31, 2007, accepted February 18, 2007.

* Reprint requests and correspondence: Dr. William R. Wagner, McGowan Institute for Regenerative Medicine, University of Pittsburgh, 100 Technology Drive, Pittsburgh, Pennsylvania 15219. (Email: wagnerwr{at}upmc.edu).

Objectives: Our objective in this study was to apply an elastic, biodegradable polyester urethane urea (PEUU) cardiac patch onto subacute infarcts and to examine the resulting cardiac ventricular remodeling and performance.

Background: Myocardial infarction induces loss of contractile mass and scar formation resulting in adverse left ventricular (LV) remodeling and subsequent severe dysfunction.

Methods: Lewis rats underwent proximal left coronary ligation. Two weeks after coronary ligation, a 6-mm diameter microporous PEUU patch was implanted directly on the infarcted LV wall surface (PEUU patch group, n = 14). Sham surgery was performed as an infarction control (n = 12). The LV contractile function, regional myocardial wall compliance, and tissue histology were assessed 8 weeks after patch implantation.

Results: The end-diastolic LV cavity area (EDA) did not change, and the fractional area change (FAC) increased in the PEUU patch group (p < 0.05 vs. week 0), while EDA increased and FAC decreased in the infarction control group (p < 0.05). The PEUU patch was largely resorbed 8 weeks after implantation and the LV wall was thicker than infarction control (p < 0.05 vs. control group). Abundant smooth muscle bundles with mature contractile phenotype were found in the infarcted myocardium of the PEUU group. The myocardial compliance of the PEUU group was distributed between normal myocardium and infarction control (p < 0.001).

Conclusions: Implantation of a novel biodegradable PEUU patch onto a subacute myocardial infarction promoted contractile phenotype smooth muscle tissue formation and improved cardiac remodeling and contractile function at the chronic stage. Our findings suggest a new therapeutic option against post-infarct cardiac failure.

Abbreviations and Acronyms
  bFGF = basic fibroblast growth factor
  CHF = congestive heart failure
  EDA = end-diastolic left ventricular cavity area
  ESA = end-systolic left ventricular cavity area
  FAC = fractional area change
  LV = left ventricular
  PEUU = polyester urethane urea
  P-E = pressure-strain
  SMA = smooth muscle actin
  SMMHC-2 = smooth muscle myosin heavy chain 2
  VEGF = vascular endothelial growth factor


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 49: A32. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J R Soc InterfaceHome page
J. R. Venugopal, M. P. Prabhakaran, S. Mukherjee, R. Ravichandran, K. Dan, and S. Ramakrishna
Biomaterial strategies for alleviation of myocardial infarction
J R Soc Interface, January 7, 2012; 9(66): 1 - 19.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. A. Rane and K. L. Christman
Biomaterials for the treatment of myocardial infarction a 5-year update.
J. Am. Coll. Cardiol., December 13, 2011; 58(25): 2615 - 2629.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Miyagawa, M. Roth, A. Saito, Y. Sawa, and S. Kostin
Tissue-Engineered Cardiac Constructs for Cardiac Repair
Ann. Thorac. Surg., January 1, 2011; 91(1): 320 - 329.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement